²é¿´: 1993  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴

striving

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúCSCDÊÕÔØµÄÎÄÕÂһƪÎÄÕ¼ìË÷ºÅ

ÌâÄ¿£º»¯Ñ§ºÏ³ÉÔ­ÁÏÒ©ÆðʼÎïÁϹúÄÚÍâÏà¹ØÒªÇóµÄ±È½Ï
ÆÚ¿¯£ºÖйúÐÂÒ©ÔÓÖ¾
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sunshan4379

°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
striving: ½ð±Ò+5 2014-10-20 15:08:46
oven1986: LS-EPI+1, ¸ÐлӦÖú£¡ 2014-10-20 15:09:34
Comparison of domestic and foreign related requirements of starting materials for synthetic drug substances
»¯Ñ§ºÏ³ÉÔ­ÁÏÒ©ÆðʼÎïÁϹúÄÚÍâÏà¹ØÒªÇóµÄ±È½Ï
×÷Õß:Wang Hongliang; Chen Zhen
×÷Õß:ÍõºêÁÁ; ³ÂÕð
Chinese Journal New Drugs
ÖйúÐÂÒ©ÔÓÖ¾
¾í:23 ÆÚ:9 Ò³:998-1003
ÎÄÏ׺Å:1003-3734(2014)23:9<998:HXHCYL>2.0.TX;2-V
³ö°æÄê:2014
ÕªÒª
The selection and quality control of starting materials are an important part of drug substance development. In the past 20 years, this topic involves in the technical requirements for drug substance registration, and gets attention quite all time. As the publication of ICH Q11 guideline, agreement on general selection principles and quality control requirements of starting materials has been reached in ICH regions. In comparison, we are still lagging behind in the understanding of this topic. In this article, we reviewed FDA, EMA, ICH and domestic related requirements of starting materials for synthetic drug substances. Furthermore, we analyzed our existing problems focusing on the regulatory function, selection principles, and document submission requirements for starting materials. We want to provide a reference to amend the domestic related requirements for starting materials.
ÕªÒª:ÆðʼÎïÁϵÄÑ¡Ôñ¼°ÖÊÁ¿¿ØÖÆÊÇÔ­ÁÏÒ©¿ª·¢µÄÖØÒª×é³É²¿·Ö¡£½ü20ÄêÀ´,ÔÚÔ­ÁÏÒ©×¢²á¼¼ÊõÒªÇóÖÐ,ÕâÒ»»°ÌâÒ»Ö±¹ãÊܹØ×¢¡£Ëæ×ÅICH Q11Ö¸µ¼Ô­ÔòµÄ³ǫ̈,ICHµØÇø¶ÔÆðʼÎïÁÏÑ¡ÔñµÄ»ù±¾Ô­Ôò¼°ÖÊÁ¿¿ØÖÆÒªÇó´ï³É¹²Ê¶¡£Ïà±È½Ï¶øÑÔ,ÎÒ¹ú¶Ô´ËÎÊÌâµÄÈÏʶÉÐÏÔÖͺ󡣱¾ÎĶÔÃÀ¹ú¡¢Å·ÃË¡¢ICHÒÔ¼°¹úÄÚ¹ØÓÚ»¯Ñ§ºÏ³ÉÔ­ÁÏÒ©ÆðʼÎïÁϵÄÏà¹ØÒªÇó½øÐÐÁË×ÛÊö,²¢¶ÔÎÒ¹úÔÚÆðʼÎïÁϵļà¹Ü×÷Óá¢Ñ¡ÔñÔ­Ôò¡¢×ÊÁÏÌá½»ÒªÇóµÈ·½Ãæ´æÔÚµÄÎÊÌâ½øÐÐÁË·ÖÎö,Ϊ½øÒ»²½ÍêÉÆÎÒ¹úµÄÏà¹ØÒªÇóÌṩ²Î¿¼¡£
¹Ø¼ü´Ê
×÷Õ߹ؼü´Ê:drug substance; starting material; guideline; technical requirements
×÷Õ߹ؼü´Ê:Ô­ÁÏÒ©; ÆðʼÎïÁÏ; Ö¸µ¼Ô­Ôò; ¼¼ÊõÒªÇó
×÷ÕßÐÅÏ¢
µØÖ·: Wang Hongliang, National Engineering Research Center for Strategic Drugs, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China.
Chen Zhen, Center for Drug Evaluation,China Food and Drug Administration, Beijing 100038, China.
µØÖ·: ÍõºêÁÁ, ¾üÊÂҽѧ¿ÆÑ§Ôº¶¾ÎïÒ©ÎïÑо¿Ëù, ¹ú¼ÒÓ¦¼±·À¿ØÒ©Î﹤³Ì¼¼ÊõÑо¿ÖÐÐÄ, ±±¾© 100850, Öйú.
³ÂÕð, ¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí×ܾÖÒ©Æ·ÉóÆÀÖÐÐÄ, ±±¾© 100038, Öйú.
µç×ÓÓʼþµØÖ·:whl.pharmacy@gmail.com, chenzh@cde.org.cn
µç×ÓÓʼþµØÖ·:whl.pharmacy@gmail.com, chenzh@cde.org.cn
Àà±ð / ·ÖÀà
Ñо¿·½Ïòharmacology & Pharmacy (ÓÉ Thomson Reuters Ìṩ)
ÎÄÏ×ÐÅÏ¢
ÎÄÏ×ÀàÐÍ:Article
ÓïÖÖ:Chinese
Èë²ØºÅ:CSCD:5139351
ISSN:1003-3734
ÆäËûÐÅÏ¢
Öйú¿ÆÑ§ÒýÎÄÊý¾Ý¿âÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 18
ÔÚÖйú¿ÆÑ§ÒýÎÄÊý¾Ý¿âÖеı»ÒýƵ´Î: 0
·Çµ­²´ÎÞÒÔÃ÷Ö¾£¬·ÇÄþ¾²ÎÞÒÔÖÂÔ¶
2Â¥2014-10-20 15:05:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sunshan4379

°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¼ìË÷ºÅ
Èë²ØºÅ:CSCD:5139351
·Çµ­²´ÎÞÒÔÃ÷Ö¾£¬·ÇÄþ¾²ÎÞÒÔÖÂÔ¶
3Â¥2014-10-20 15:08:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ striving µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[˶²©¼ÒÔ°] ÊÛT0PÒ»ÇøSCIÎÄÕ£¬ÎÒ:8O5.51.O.54,¿ÆÄ¿ÆëÈ«,¿É£«¼± +3 bjm2e4yior 2026-07-18 3/150 2026-07-19 16:43 by 0u3sh5hhfi
[ÂÛÎÄͶ¸å] ÊÛT0PÒ»ÇøSCIÎÄÕ£¬ÎÒ:8O5.51.O.54,¿ÆÄ¿ÆëÈ«,¿É£«¼± +3 ufgqpyvpi6 2026-07-18 6/300 2026-07-19 16:23 by 0u3sh5hhfi
[¿¼²©] ÊÛT0PÒ»ÇøSCIÎÄÕ£¬ÎÒ:8O5.51.O.54,¿ÆÄ¿ÆëÈ«,¿É£«¼± +3 ufgqpyvpi6 2026-07-18 4/200 2026-07-19 16:10 by 0u3sh5hhfi
[½Ìʦ֮¼Ò] ÊÛT0PÒ»ÇøSCIÎÄÕ£¬ÎÒ:8O5.51.O.54,¿ÆÄ¿ÆëÈ«,¿É£«¼± +3 ufgqpyvpi6 2026-07-18 6/300 2026-07-19 16:03 by 0u3sh5hhfi
[»ù½ðÉêÇë] ¹úÉç¿ÆÍ¨Ñ¶ÆÀÉó +5 DZˮ¹Ú¾ü123 2026-07-18 6/300 2026-07-19 12:28 by lfy8008
[»ù½ðÉêÇë] ÃæÉϵÄË®ºÜÉî +16 ²¼²¼ºÍÒ»¶þ 2026-07-18 21/1050 2026-07-19 10:07 by Vivilian
[»ù½ðÉêÇë] Сľ³æÃ»ÂäÁË£¬³ýÁËÆíµ»Ìû×Ó£¬¼¸ºõ¿´²»µ½ÓмÛÖµµÄÌû×Ó +14 botar 2026-07-14 15/750 2026-07-19 00:15 by beefly
[»ù½ðÉêÇë] 5¸ö%2F£¬·Ç¹Ì¶¨¶Î22¸ö×Öĸ +8 jaasxulu 2026-07-15 9/450 2026-07-18 17:40 by dxcgbm
[»ù½ðÉêÇë] ÉúÃü¿ÚC13ÃæÉÏ»áÆÀʱ¼ä +7 luckinging 2026-07-14 11/550 2026-07-17 20:43 by ³æ²·1988
[»ù½ðÉêÇë] ÉúÃü¿ÚÃæÉÏ»áÆÀ½áÊøÁËÂð´ó¼ÒÓÐÖªµÀ½á¹ûÂð£¿ÏÖÔÚ»¹Ã»Óнá¹ûÕý³£²»£¿ +6 ±ÌË®00 2026-07-16 9/450 2026-07-17 15:21 by jaasxulu
[ÂÛÎÄͶ¸å] ͶӢÎÄÆÚ¿¯ÈçºÎ²éÖØ 10+5 ²»ÖªµÀȡʲôÃû× 2026-07-15 6/300 2026-07-17 09:07 by bobvan
[Óлú½»Á÷] ²®°·Éϼ׻ùÇóÖú 100+4 002tmumu 2026-07-14 7/350 2026-07-16 19:47 by 002tmumu
[ÂÛÎÄͶ¸å] ¿ç³ö°æÉçÉÌͶ¸å 20+5 ÄߺÃ520 2026-07-13 5/250 2026-07-16 17:24 by ÎÞÊÓ¾üÍÅ
[»ù½ðÉêÇë] H¿Ú£¬ÃæÉÏ£¬Ê±¼ä´Á7ÔÂ7ÈÕ¡£ +3 plumage5 2026-07-15 3/150 2026-07-15 21:06 by 6543yes
[»ù½ðÉêÇë] »áÆÀ +5 ÎÞÃûÕßµÇɽ 2026-07-15 5/250 2026-07-15 18:15 by ¸Ü¾ÍÊÇÄã¶Ô
[»ù½ðÉêÇë] E¿Ú»áÆÀ +11 ²¼²¼ºÍÒ»¶þ 2026-07-13 13/650 2026-07-15 16:34 by Kittylucky
[»ù½ðÉêÇë] E¿ÚÇàC»áÆÀ½áÊøÁËÂ𣿠40+3 ССÊ鳿c 2026-07-14 9/450 2026-07-15 16:04 by °²¾²µÄÖªÁË
[ÂÛÎÄͶ¸å] ũҵ»úеѧ±¨Í¶¸åÖÜÆÚ +3 G0DLIN 2026-07-14 7/350 2026-07-15 09:26 by xs74101122
[»ù½ðÉêÇë] ¹ú×ÔÈ»ÃæÉÏD¿ÚÆíµ» +4 monkeynana 2026-07-14 4/200 2026-07-15 09:14 by °×Ë®Öó
[»ù½ðÉêÇë] Ã÷ÌìE¿ÚÃæÉÏ»áÆÀ +8 ²¼²¼ºÍÒ»¶þ 2026-07-12 9/450 2026-07-13 22:59 by QTSorange
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û